Cerebrospinal fluid progesterone in pregnant women.
To assess the possible relationship between an increase in progesterone concentration in cerebrospinal fluid (CSF) and enhancement of spread of spinal anaesthesia, we have measured CSF progesterone concentrations in 134 patients undergoing spinal anaesthesia with hyperbaric amethocaine 8 mg. Patients were allocated to one of five groups according to the gestational period: non-pregnant group (n = 13), first trimester group (8-12 weeks, n = 16), second trimester group (13-24 weeks, n = 18), third trimester group (25-36 weeks, n = 38) and term group (37-41 weeks, n = 49). Progesterone concentration in CSF was higher in the third trimester and term groups than in the non-pregnant, first trimester and second trimester groups. Maximum cephalad spread of analgesia was higher in the second trimester, third trimester and term groups than in the non-pregnant and first trimester groups. Although an increase in CSF progesterone concentration in the second trimester group was similar in magnitude to that observed in the first trimester group, enhanced spread of spinal anaesthesia, comparable in magnitude with that observed in the term group, occurred in the second trimester group. There was no significant correlation between CSF progesterone concentration and spread of spinal anaesthesia in any of the groups. These data suggest that not only a minimum level of progesterone in CSF but also a certain duration of exposure to elevated CSF progesterone concentrations may be necessary for enhancement of spread of spinal anaesthesia, and that values of CSF progesterone concentration do not correlate directly with enhancement of spread of spinal anaesthesia.
Hirabayashi
Y
Y
Department of Anaesthesiology, Jichi Medical School, Tochigi, Japan.
Shimizu
R
R
Saitoh
K
K
Fukuda
H
H
D000328:Adult; D000773:Anesthesia, Obstetrical; D000775:Anesthesia, Spinal; D000779:Anesthetics, Local / Q000493:pharmacokinetics*; D016022:Case-Control Studies; D005260:Female; D005865:Gestational Age; D006801:Humans; D011247:Pregnancy / Q000134:cerebrospinal fluid*; D011272:Pregnancy, Multiple / Q000134:cerebrospinal fluid; D011374:Progesterone / Q000134:cerebrospinal fluid*; D013748:Tetracaine / Q000493:pharmacokinetics
D000779:Anesthetics, Local; D013748:Tetracaine; D011374:Progesterone